LBTD (Lotus Bio-Technology Development) Total Liabilities: $0.12 Mil (As of Dec. 2017)


What is Lotus Bio-Technology Development Total Liabilities?

Lotus Bio-Technology Development LBTD -99.99% Total Liabilities is $0.12 Mil as of Dec. 2017.

Lotus Bio-Technology Development's Total Liabilities for the quarter that ended in Dec. 2017 was $0.12 Mil.

Lotus Bio-Technology Development's quarterly Total Liabilities stayed the same from Jun. 2017 ($0.00 Mil) to Sep. 2017 ($0.00 Mil) but then increased from Sep. 2017 ($0.00 Mil) to Dec. 2017 ($0.12 Mil).

Lotus Bio-Technology Development's annual Total Liabilities increased from Mar. 2015 ($0.05 Mil) to Mar. 2016 ($0.07 Mil) and increased from Mar. 2016 ($0.07 Mil) to Mar. 2017 ($0.08 Mil).

Lotus Bio-Technology Development Total Liabilities Historical Data

* Premium members only.

The historical data trend for Lotus Bio-Technology Development's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Total Liabilities Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Total Liabilities
Get a 7-Day Free Trial 0.01 0.03 0.05 0.07 0.08

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.00 0.00 0.12

Lotus Bio-Technology Development Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lotus Bio-Technology Development's Total Liabilities for the fiscal year that ended in Mar. 2017 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.081+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.08

Total Liabilities=Total Assets (A: Mar. 2017 )-Total Equity (A: Mar. 2017 )
=N/A--0.081
=N/A

Lotus Bio-Technology Development's Total Liabilities for the quarter that ended in Dec. 2017 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.067+(0+0.05
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.12

Total Liabilities=Total Assets (Q: Dec. 2017 )-Total Equity (Q: Dec. 2017 )
=0.055--0.061
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.12 Mil mean?
Lotus Bio-Technology Development (LBTD) has a Total Liabilities of $0.12 Mil as of Dec. 2017. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lotus Bio-Technology Development and its competitors.
Is Lotus Bio-Technology Development's Total Liabilities too high?
Lotus Bio-Technology Development's current Total Liabilities is $0.12 Mil.
How does Lotus Bio-Technology Development's Total Liabilities compare to SNES and CVAT?
Lotus Bio-Technology Development's Total Liabilities of $0.12 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for an Agriculture company?
A good Total Liabilities depends on the Agriculture industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lotus Bio-Technology Development and its competitors. Lotus Bio-Technology Development's current Total Liabilities is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Bio-Technology Development stock overvalued right now?
Lotus Bio-Technology Development (LBTD) has a current Total Liabilities of $0.12 Mil. The current Total Liabilities is $0.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Lotus Bio-Technology Development (LBTD), the current Total Liabilities is $0.12 Mil as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lotus Bio-Technology Development Business Description

Address 108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is actively seeking out new opportunities in the Organic and Bio-technology space.